Latest Operating Cashflow News

Althea Group Holdings reported $5.02 million in Q3 FY25 receipts, driven by strong growth at Peak Canada and the launch of Peak USA, while its pharmaceutical cannabis division faces steep revenue declines prompting strategic review.

Resonance Health reports record $14.9M cash receipts over 12 months and completes cost-cutting measures while advancing two major pharma clinical trials on schedule.

Medical Developments International reported a robust Q3 FY25 with $8.9 million revenue and $1.7 million operating cashflow, driven by strong Penthrox demand and pricing. New distribution agreements in France and Switzerland position the company for further European expansion.

RMA Global Limited reported a robust Q3 FY25, achieving a 21% revenue increase to $5.5 million and marking its third consecutive quarter of positive operating cash flow, driven by US market expansion and the strategic acquisition of Curated Social.

AIC Mines reported solid copper production at Eloise with significant resource upgrades at both Eloise and Jericho, despite weather-related shipment delays. The company is progressing its processing plant expansion with a contract award expected soon.

Alcidion Group Limited reported a robust Q3 FY25 with $13.1 million in cash receipts and a landmark 10-year $37.5 million contract with North Cumbria NHS Trust, prompting an upgrade to its full-year EBITDA guidance.

Sheffield Resources delivered a standout quarter with record mineral sands shipments and positive operating cashflow from its Thunderbird Mine joint venture, setting the stage for a significant production increase by 2027.

Dreadnought Resources has inked a $1 million share subscription deal with Black Cat Syndicate, securing a pivotal development right for the Star of Mangaroon gold project and setting the stage for drilling to commence in early 2025.

Bridge SaaS Limited has recorded its first cashflow positive quarter, driven by strong growth at Brightside and strategic moves into the NDIS and DES sectors. The company is advancing plans for a tailored NDIS 'lite' SaaS offering aimed at smaller providers.

Field Solutions Holdings reports a neutral operating cashflow for Q2 2024, while navigating a trading halt and preparing for a capital raise alongside key business divestments.

Skin Elements Limited reports steady progress in commercialising its plant-based SE Formula biotechnology, highlighted by ongoing product trials, a successful R&D rebate, and a $513k non-renounceable entitlement issue.

8common Limited reports a record $1.2 million in SaaS revenue for Q2 FY25, driven by a 12% increase in users and strong government contract activity. Despite tight cash balances, the company remains funded through a chairman-backed facility.